Tenofovir for the Prevention of HCC in Patients With Cirrhosis

dc.authorid	0000-0001-8217-1767
dc.contributor.author	Arslan, Ferhat
dc.contributor.author	Vahaboğlu, Haluk
dc.date.accessioned	2025-05-10T19:34:49Z
dc.date.issued	2020
dc.department	İstanbul Medeniyet Üniversitesi
dc.description.abstract	[No abstract available]
dc.identifier.doi	10.14309/ajg.0000000000000477
dc.identifier.endpage	302
dc.identifier.issn	0002-9270
dc.identifier.issn	1572-0241
dc.identifier.issue	2
dc.identifier.pmid	31850932
dc.identifier.scopus	2-s2.0-85079022822
dc.identifier.scopusquality	Q1
dc.identifier.startpage	302
dc.identifier.uri	https://doi.org/10.14309/ajg.0000000000000477
dc.identifier.uri	https://hdl.handle.net/20.500.14730/8657
dc.identifier.volume	115
dc.identifier.wos	WOS:000540835600024
dc.identifier.wosquality	Q1
dc.indekslendigikaynak	Web of Science
dc.indekslendigikaynak	Scopus
dc.indekslendigikaynak	PubMed
dc.language.iso	en
dc.publisher	Lippincott Williams & Wilkins
dc.relation.ispartof	American Journal of Gastroenterology
dc.relation.publicationcategory	Diğer
dc.rights	info:eu-repo/semantics/closedAccess
dc.snmz	KA_WOS_20250302
dc.subject	Reverse-Transcriptase Inhibitors
dc.subject	Telomerase Function
dc.title	Tenofovir for the Prevention of HCC in Patients With Cirrhosis
dc.type	Letter

Dosyalar

Listeleniyor 1 - 1 / 1